BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37924516)

  • 1. Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
    Berico P; Nogaret M; Cigrang M; Lallement A; Vand-Rajabpour F; Flores-Yanke A; Gambi G; Davidson G; Seno L; Obid J; Vokshi BH; Le Gras S; Mengus G; Ye T; Cordero CF; Dalmasso M; Compe E; Bertolotto C; Hernando E; Davidson I; Coin F
    Cell Rep; 2023 Nov; 42(11):113363. PubMed ID: 37924516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
    Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
    Elife; 2015 Mar; 4():. PubMed ID: 25803486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
    Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
    J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis.
    Fan H; Lu J; Guo Y; Li D; Zhang ZM; Tsai YH; Pi WC; Ahn JH; Gong W; Xiang Y; Allison DF; Geng H; He S; Diao Y; Chen WY; Strahl BD; Cai L; Song J; Wang GG
    Nat Genet; 2020 Dec; 52(12):1384-1396. PubMed ID: 33139953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma.
    Zhou B; Wang L; Zhang S; Bennett BD; He F; Zhang Y; Xiong C; Han L; Diao L; Li P; Fargo DC; Cox AD; Hu G
    Genes Dev; 2016 Jun; 30(12):1440-53. PubMed ID: 27340176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
    Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
    Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
    Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
    PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma.
    Liu SX; Wang C; Lin RB; Ding WY; Roy G; Wang HB; Yang T; Liu Q; Luo YL; Jin SL; Zeng MS; Zhao B; Zhong Q
    EBioMedicine; 2023 Dec; 98():104870. PubMed ID: 37967508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of long and short enhancers in melanoma cell states.
    Mauduit D; Taskiran II; Minnoye L; de Waegeneer M; Christiaens V; Hulselmans G; Demeulemeester J; Wouters J; Aerts S
    Elife; 2021 Dec; 10():. PubMed ID: 34874265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition.
    Gelato KA; Schöckel L; Klingbeil O; Rückert T; Lesche R; Toedling J; Kalfon E; Héroult M; Lejeune P; Mönning U; Fernández-Montalván AE; Bäurle S; Siegel S; Haendler B
    Oncogene; 2018 Jan; 37(4):512-521. PubMed ID: 28991225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.
    Lin L; Huang M; Shi X; Mayakonda A; Hu K; Jiang YY; Guo X; Chen L; Pang B; Doan N; Said JW; Xie J; Gery S; Cheng X; Lin Z; Li J; Berman BP; Yin D; Lin DC; Koeffler HP
    Nucleic Acids Res; 2019 Feb; 47(3):1255-1267. PubMed ID: 30496486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    Ri K; Kim C; Pak C; Ri P; Om H
    Microrna; 2020; 9(1):64-69. PubMed ID: 30868974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
    Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.